Molecular Hydrogen Modulates T Cell Differentiation and Enhances Neuro-Regeneration in a Vascular Dementia Mouse Model.
Dain Lee, Hyunjun Jo, Jong-Il Choi · Antioxidants (Basel, Switzerland) · 2025
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In male C57BL/6 mice, analysis of CD4 + CD25 + cells (one-way ANOVA) showed that this subset was significantly decreased in the H₂ -treated group (n = 8) compared to the Sham group (n = 9; p = 0.0325), whereas no significant difference was observed between the VaD group (n = 8) and Sham group ( p = 0.7609). These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water affected the outcomes measured in male C57BL/6 mice. Analysis of CD4 + CD25 + cells (one-way ANOVA) showed that this subset was significantly decreased in the H₂ -treated group (n = 8) compared to the Sham group (n = 9; p = 0.0325), whereas no significant difference was observed between the VaD group (n = 8) and Sham group ( p = 0.7609).
What the Researchers Studied
The researchers studied male C57BL/6 mice. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 1.000 mg/L H₂; Source-reported hydrogen exposure: 1.000 mg/L H₂. Analysis of CD4 + CD25 + cells (one-way ANOVA) showed that this subset was significantly decreased in the H₂ -treated group (n = 8) compared to the Sham group (n = 9; p = 0.0325), whereas no significant difference was observed between the VaD group (n = 8) and Sham group ( p = 0.7609). The authors concluded that these findings highlight the neuroprotective and immuno-modulatory potential of molecular hydrogen, suggesting that H₂ supplementation may promote neuronal resilience, modulate T cell differentiation, and support cognitive recovery in vascular dementia. The researchers conducted a study designed to establish the effect of hydrogen-rich water (HRW) on a mouse model of VaD and to analyze the mechanism of action of H₂.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was male C57BL/6 mice. The study used a preclinical animal experiment. The hydrogen delivery method was hydrogen-rich water. The source-reported hydrogen concentration was 1.000 mg/L H₂. The source-reported hydrogen exposure was 1.000 mg/L H₂.
Limitations and Safety
Reported limitations: In detail, a one-way ANOVA was performed (post hoc Dunn’s multiple comparison test), focusing on markers related to neurogenesis and synaptic remodeling (Igf2, Gap43), immune DISCUSSION: Although this model can sometimes lead to only mild cerebral blood flow reduction, the researchers addressed this limitation by using a smaller diameter coil (0.16 mm) instead of the standard 0.18 mm coil. While this study highlights the promise of H₂ therapy, limitations such as variability in oral intake and challenges in precise dosage delivery require further refinement.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.